ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	19/159	120/7206	9.94463273829e-12
ko04621	NOD-like receptor signaling pathway	19/159	157/7206	1.18251938006e-09
ko05131	Shigellosis	14/159	82/7206	2.19696242698e-09
ko04210	Apoptosis	19/159	180/7206	1.19511254676e-08
ko05132	Salmonella infection	14/159	98/7206	2.40367056598e-08
ko05100	Bacterial invasion of epithelial cells	14/159	99/7206	2.7467344484e-08
ko05161	Hepatitis B	17/159	173/7206	2.12139286296e-07
ko04217	Necroptosis	17/159	178/7206	3.2056798409e-07
ko05164	Influenza A	16/159	167/7206	6.97633975082e-07
ko04064	NF-kappa B signaling pathway	11/159	96/7206	7.47570201956e-06
ko05152	Tuberculosis	15/159	187/7206	1.43069804295e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	15/159	191/7206	1.84361466899e-05
ko04623	Cytosolic DNA-sensing pathway	7/159	41/7206	2.66915837758e-05
ko05130	Pathogenic Escherichia coli infection	9/159	77/7206	4.41975802961e-05
ko04666	Fc gamma R-mediated phagocytosis	11/159	122/7206	7.26167006926e-05
ko04380	Osteoclast differentiation	11/159	134/7206	0.000169422124567
ko04144	Endocytosis	19/159	342/7206	0.000174973635536
ko04933	AGE-RAGE signaling pathway in diabetic complications	11/159	135/7206	0.000180988463682
ko04722	Neurotrophin signaling pathway	12/159	160/7206	0.000202072976966
ko05162	Measles	10/159	120/7206	0.00029774489517
ko04620	Toll-like receptor signaling pathway	9/159	100/7206	0.000338265782439
ko05203	Viral carcinogenesis	16/159	277/7206	0.000379327156717
ko01522	Endocrine resistance	10/159	124/7206	0.000388170134709
ko05142	Chagas disease (American trypanosomiasis)	10/159	130/7206	0.000565937959219
ko05133	Pertussis	8/159	87/7206	0.000627938115742
ko05168	Herpes simplex infection	12/159	182/7206	0.000657884742785
ko04932	Non-alcoholic fatty liver disease (NAFLD)	12/159	182/7206	0.000657884742785
ko04624	Toll and Imd signaling pathway	6/159	49/7206	0.000670044897456
ko04810	Regulation of actin cytoskeleton	15/159	264/7206	0.000689218360889
ko05120	Epithelial cell signaling in Helicobacter pylori infection	8/159	92/7206	0.000911473464799
ko05134	Legionellosis	7/159	74/7206	0.00116210016487
ko04660	T cell receptor signaling pathway	9/159	124/7206	0.0016096477563
ko04670	Leukocyte transendothelial migration	10/159	151/7206	0.00179195475677
ko04657	IL-17 signaling pathway	7/159	87/7206	0.00297279307163
ko04662	B cell receptor signaling pathway	7/159	88/7206	0.00317110818968
ko04215	Apoptosis - multiple species	5/159	47/7206	0.00356665710662
ko05418	Fluid shear stress and atherosclerosis	10/159	173/7206	0.00480610776854
ko04912	GnRH signaling pathway	8/159	122/7206	0.00540910945694
ko04115	p53 signaling pathway	6/159	74/7206	0.00565067118624
ko05140	Leishmaniasis	6/159	75/7206	0.00603260853119
ko05146	Amoebiasis	7/159	99/7206	0.00608204677755
ko01524	Platinum drug resistance	6/159	76/7206	0.00643304707811
ko04610	Complement and coagulation cascades	6/159	79/7206	0.00775036746507
ko04630	Jak-STAT signaling pathway	8/159	132/7206	0.00860254027959
ko04622	RIG-I-like receptor signaling pathway	5/159	62/7206	0.0115589192247
ko05205	Proteoglycans in cancer	12/159	271/7206	0.0185308206419
ko05160	Hepatitis C	8/159	153/7206	0.0196423482686
ko05219	Bladder cancer	4/159	48/7206	0.0209236375692
ko04510	Focal adhesion	11/159	240/7206	0.0211772134212
ko05014	Amyotrophic lateral sclerosis (ALS)	5/159	74/7206	0.0233388344601
ko04080	Neuroactive ligand-receptor interaction	3/159	423/7206	0.0254914510001
ko04915	Estrogen signaling pathway	7/159	131/7206	0.0255071551824
ko00590	Arachidonic acid metabolism	4/159	52/7206	0.0272175157561
ko04137	Mitophagy - animal	5/159	82/7206	0.034409691277
ko05200	Pathways in cancer	18/159	492/7206	0.0363451610288
ko04060	Cytokine-cytokine receptor interaction	9/159	191/7206	0.0384630446613
ko05210	Colorectal cancer	5/159	86/7206	0.0409860674757
ko05323	Rheumatoid arthritis	5/159	89/7206	0.0463862573225